Literature DB >> 7085627

Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.

R J Linhardt, A Grant, C L Cooney, R Langer.   

Abstract

Heparin of an average molecular weight of 13,000 with known polydispersity was degraded using microbial heparinase. The kinetics of this degradation were followed by four assays which measured the anticoagulant activity of the heparin digestion products. Both clotting and amidolytic chromogenic assays were used to measure heparin-potentiated inhibition of both thrombin and Factor Xa. These assays showed different profiles throughout the digestion and were related to the average molecular weight of the digestion products.l The final products of this enzymatic digestion were fractionated on the basis of size and their anticoagulant activities were measured. Fragments causing Factor Xa inhibition but not thrombin inhibition were isolated. Anticoagulant activity was found in a fragment as small as a tetrasaccharide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Specific plate assay for bacterial heparinase.

Authors:  J J Zimmermann; R Langer; C L Cooney
Journal:  Appl Environ Microbiol       Date:  1990-11       Impact factor: 4.792

2.  Ex vivo model of an immobilized-enzyme reactor.

Authors:  H Bernstein; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Oral heparin results in the appearance of heparin fragments in the plasma of rats.

Authors:  A K Larsen; D P Lund; R Langer; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Photochemical Preparation of a Novel Low Molecular Weight Heparin.

Authors:  Kyohei Higashi; Saori Hosoyama; Asami Ohno; Sayaka Masuko; Bo Yang; Eric Sterner; Zhenyu Wang; Robert J Linhardt; Toshihiko Toida
Journal:  Carbohydr Polym       Date:  2012-02-01       Impact factor: 9.381

5.  Mapping and quantification of the major oligosaccharide components of heparin.

Authors:  R J Linhardt; K G Rice; Y S Kim; D L Lohse; H M Wang; D Loganathan
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

6.  Ozonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan.

Authors:  Sayaka Masuko; Kyohei Higashi; Zhenyu Wang; Ujjwal Bhaskar; Anne Marie Hickey; Fuming Zhang; Toshihiko Toida; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2011-06-22       Impact factor: 2.104

7.  An immobilized microbial heparinase for blood deheparinization.

Authors:  R J Linhardt; C L Cooney; D Tapper; C A Zannetos; A K Larsen; R Langer
Journal:  Appl Biochem Biotechnol       Date:  1984-02       Impact factor: 2.926

8.  Heparin inhibits EcoRI endonuclease cleavage of DNA at certain EcoRI sites.

Authors:  J Z Chen; L A Herzenberg; L A Herzenberg
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

9.  The release of heparinase from the periplasmic space of Flavobacterium heparinum by three-step osmotic shock.

Authors:  J J Zimmermann; K Oddie; R Langer; C L Cooney
Journal:  Appl Biochem Biotechnol       Date:  1991-08       Impact factor: 2.926

10.  Kinetics of immobilized heparinase in human blood.

Authors:  L E Freed; G V Vunjak-Novakovic; H Bernstein; C L Cooney; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.